Alpha Teknova (TKNO) and Pluristyx said late Tuesday they are collaborating to produce and commercialize the latter's PluriFreeze product line, a cryopreservative and cell wash media system for allogeneic cell therapies.
Under the partnership, the companies said Teknova will be the exclusive manufacturer and distributor of PluriFreeze in the US and Canada.
The PluriFreeze system, which is entirely synthetic and animal-origin-free, includes a protective wash and a freezing medium designed to support cell therapy development, the companies said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.